Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Imfinzi
Active Ingredient: Durvalumab 120mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AstraZeneca AB, Sodertalje, Sweden
Catalent Indiana LLC, Indiana, United States of America
   
Product: Imfinzi
Active Ingredient: Durvalumab 500mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
AstraZeneca AB, Sodertalje, Sweden
Catalent Indiana LLC, Indiana, United States of America


Dated this 27th day of January 2023.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).